J.P. Morgan Initiates Hims & Hers Health with Overweight Rating

Shares of Hims & Hers Health (HIMS) trended higher on Friday following the initiation of coverage by J.P. Morgan. The investment bank assigned an 'Overweight' rating to the telehealth platform, signaling strong confidence in the company's growth trajectory. Analyst Cory Carpenter highlighted what he described as a 'compelling catalyst path' for the company. This initiation suggests that the firm sees significant untapped potential or upcoming operational milestones that could drive the stock's valuation higher over the next two years. The bank established a specific price target of $35 for December 2026. This target reflects a positive outlook on the company's ability to scale its telehealth services and capture additional market share within its specialized health segments. The market responded positively to the news, with HIMS shares gaining ground during the session. Investors typically view initiations from top-tier institutions like J.P. Morgan as a validation of a company's business model and future earnings potential.